Big Pharma invests millions as Congress readies drug pricing bills September 25, 2019 Center for Responsive Politics Share Tweet SUMMARY: The battle over prescription drug prices continues in Congress. Meanwhile, pharmaceutical companies are upping campaign contributions – as sweeping legislation aimed at lowering drug prices heads to the floor. North Carolinians know that drug costs are too high. Democrats are in favor of giving Medicare the power to negotiate drug prices. Nine in ten Americans support this measure. But Republicans… along with Big Pharma aren’t on board. Meanwhile, drug companies are giving millions of dollars in donations to key decision makers in Congress.